ArticleCureus2025
Association of Psoriasis With Thyroid Disorders: A Tertiary Center-Based Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Associations Between Psoriasis and Endocrine Diagnoses in a Tertiary-Center Electronic Health Record Database: A Cross-Sectional Study.Clinical, cosmetic and investigational dermatology · 2026Article
- Advances in Psoriasis Research: Decoding Immune Circuits and Developing Novel Therapies.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Psoriasis is a chronic inflammatory skin disease associated with various entities. Despite indications of a correlation, this relationship remains poorly understood due to inconsistent findings in previous studies and the lack of sufficient data. This study aims to investigate thyroid dysfunction and autoimmunity prevalence in psoriasis patients at King Abdulaziz Medical City, Riyadh and explores their relationship with gender, age, and disease duration. Methods A retrospective cross-sectional study was conducted involving psoriasis patients diagnosed between 2015 and 2023. We included patients aged 18 or older with a confirmed psoriasis diagnosis. We excluded patients under 18, pregnant or lactating women, and those with pre-existing thyroid conditions or treatments affecting thyroid function. Statistical analyses were performed using SPSS Inc. Released 2003. SPSS for Windows, Version 12.0. Chicago, SPSS Inc., with significance set at p < 0.05. Results One hundred and nineteen individuals, with 41 males (34.4%) and 78 females (65.6%), were part of the study. The average age was 44.19 years. The average disease duration was 5.35 years. The most common initial sites of involvement were the extremities (35.3%), the scalp (25.2%), and the trunk (10%). The most prevalent type was chronic plaque psoriasis (74.8%), pustular (12.6%), erythrodermic (4.2%), palmoplantar (3.4%), guttate (2.5%), and unknown (2.5%). Thyroid function tests revealed that 38.7% had abnormalities, with 31.1% elevated thyroid-stimulating hormone (TSH) and 7.6% low TSH. Triiodothyronine (FT3) levels varied, with 9.2% having low FT3 and 10.9% having high FT3. Moreover, Thyroxine (FT4) also varies, with 7.6% having low FT4 and 2.5% having high FT4. Elevated antithyroglobulin antibodies (anti-TG) and thyroid peroxidase antibodies (anti-TPO) were observed in 12.6% and 16.0% of subjects, respectively. Conclusion The study revealed a notable prevalence of thyroid dysfunction among psoriasis patients, with no direct correlation between psoriasis types and thyroid abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.